Unlike the three most common forms of breast cancer, triple negative breast cancer has no currently approved targeted therapies for treatment. That was one of the reasons it was chosen as a disease area of focus for the Indiana University Precision Health Grand Challenge initiative, aimed to research and develop better treatments, cures or preventions, […]Continue Reading ...
Like many other patients who have overcome cancer, breast cancer survivors live in fear of relapse. Now, researchers have developed a tool by which they can predict accurately the time when the cancer is likely to return. The results of this study were published in the latest issue of the journal Nature. The new test […]Continue Reading ...
Breast cancer survivors like many other cancer survivors live in fear of relapse of their cancer after they have been in remission. Researchers have now developed a tool by which they can predict accurately the time when the cancer is likely to return. The results of this study were published in the latest issue of […]Continue Reading ...
WEDNESDAY, March 13, 2019 — Figuring out which breast cancer patients will live disease-free after treatment is a bit of a guessing game. But new research indicates breast cancer cells hold molecular clues that may allow doctors to predict who is at high risk of having a recurrence up to 20 years later. It has […]Continue Reading ...
WEDNESDAY, March 13, 2019 — The correlation between reproductive events and breast cancer risk varies for BRCA1 and BRCA2 mutation carriers, according to a study published March 8 in JNCI Cancer Spectrum. Mary Beth Terry, Ph.D., from Columbia University in New York City, and colleagues examined whether reproductive events are associated with breast cancer risk […]Continue Reading ...
Scientists at the University of Illinois have found that free fatty acids in the blood appear to boost proliferation and growth of breast cancer cells. The finding could help explain obese women’s elevated risk of developing breast cancer after menopause. “When taken up by estrogen-receptor positive breast cancer cells, these fatty acids activated pathways that […]Continue Reading ...
Molecular data obtained from breast cancer cells can be used to predict which patients are at a high risk for recurrence even decades after their diagnosis, according to a new study jointly conducted by researchers at the Stanford University School of Medicine and the Cancer Research UK Cambridge Institute, as well as several other institutions. […]Continue Reading ...
A qualitative study led by researchers at the Johns Hopkins Bloomberg School of Public Health yielded nine patient-driven recommendations across circumstances that include changes to insurance, supportive services and financial assistance to reduce long-term, breast cancer-related economic burden. The study appears online March 6 in the journal Cancer. U.S. breast cancer patients experience considerable economic […]Continue Reading ...
Henry Ford Cancer Institute is the first in Michigan to offer a needle-free, patient-controlled tissue expansion system for women undergoing breast reconstruction after mastectomy. The FDA-approved AeroForm Tissue Expanders eliminate the need for weekly saline injections at the physician’s office, improves patient comfort and may decrease the rate of expander infection. Instead, the system fills […]Continue Reading ...
Mar 14 2019 The genetic and molecular make-up of individual breast tumors holds clues to how a woman’s disease could progress, including the likelihood of it coming back after treatment, and in what time frame, according to a Cancer Research UK-funded study published in Nature today (Wednesday). In the first study of its kind, scientists […]Continue Reading ...
Researchers at the George Washington University (GW) Cancer Center found that the enzyme USP15 could potentially lead to new treatments for breast and pancreatic cancer. Their findings were published in Nature Communications. “With this study, we validate the role of USP15 in maintaining genome stability and tumor suppression and inform novel treatments for breast cancer,” […]Continue Reading ...
It has long been thought that stress contributes to cancer progression. Scientists from the University of Basel and the University Hospital of Basel have deciphered the molecular mechanisms linking breast cancer metastasis with increased stress hormones. In addition, they found that synthetic derivatives of stress hormones, which are frequently used as anti-inflammatory in cancer therapy, […]Continue Reading ...
Women successfully treated for breast cancer and their clinicians often want to know whether, when and where their tumors are likely to recur. It’s a million dollar question with no clear answer. But now cancer geneticist Christina Curtis, PhD, together with colleagues from the Cancer Research UK Cambridge Institute, have shown that a close look at the […]Continue Reading ...
Treating sick babies with engineered breast milk could someday be a reality, according to an article in Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society. Modified cells in the liquid could potentially deliver vaccines, fix birth defects or provide proteins that some babies can’t make on their own. At the […]Continue Reading ...
Thousands of younger women with no known breast cancer risk get mammograms before breast reduction surgery, a Michigan Medicine study shows. Credit: Manifest for Michigan Medicine Each year, thousands of younger women with no known risk of breast cancer get mammograms before having breast reduction surgery. Patients receive the exam, often at the suggestion of […]Continue Reading ...
- New nanotechnology approach shows promise in treating triple negative breast cancer
- Trevena Announces Publication of APOLLO-1 Results in The Journal of Pain Research Highlighting Oliceridine’s Potential for Management of Moderate-to-Severe Acute Pain
- Maternal deaths following C-section 50 times higher in Africa compared to high-income countries
- Apple watch could detect irregular heart beat says study
- Queen Mary University of London’s BCI boosts radionuclide imaging capabilities with MILabs VECTor technology
- Girls should be encouraged to gain more ball skills, shows study
- Acute doses of synthetic cannabinoid can impair critical thinking and memory
- Presence of bacteria in urine does not always point to infection, shows study
- Scientists identify a new role for nerve-supporting cells
- Hidden differences between pathology of CTE and Alzheimer’s disease discovered
- Knowing causative genes of osteoporosis may open door to more effective treatments
- Toilet-seat based cardiovascular monitoring system getting ready to begin commercialization
- New model for intensive care identifies factors that send ill patients to ICU
- Recommendations Issued for HSCT in Multiple Myeloma
- Deep brain stimulation provides sustained relief for severe depression
- “Statistical significance” may soon be a thing of past?
- Researchers track effects of epigenetic marks carried by sperm chromosomes
- AHA News: Family Adopts Three Children With Three Different Heart Conditions
- Research into opioid painkillers could provide clues for safer drug development
- Lung cancer survivor recounts her lifetime struggles